Odyssey Therapeutics, Inc.
NASDAQ:ODTX · NASDAQ Global Market
-$0.01 today
Vol 1.15M · Avg 0.43M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jason Haas | Chief Financial Officer | $702,500.00 | — | 58 | — | — |
Gary D. Glick | Founder, President, CEO & Director | $558,900.00 | — | 64 | — | — |
Collin Todd | Senior Vice President of Strategy & Business Development | $544,900.00 | — | 34 | — | — |
Eicke Latz | Scientific Co-Founder | — | — | — | — | — |
Joseph McDonald | Chief Data Officer | — | — | — | — | — |
Natalie Dales | Chief of Research Operations & Portfolio Strategy | — | — | 56 | — | — |
Jolie Siegel | Executive VP, General Counsel & Secretary | — | — | 49 | — | — |
Felix Meissner | Scientific Co-Founder | — | — | — | — | — |
Florian.I Schmidt | Scientific Co-Founder | — | — | — | — | — |
Kim Lewis | Scientific Co-Founder | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
No competitor data available.
Who manages ODTX?
Odyssey Therapeutics, Inc. (ODTX) lists 10 active executives. The top listed executive is Eicke Latz, Scientific Co-Founder.
Explore More
Continue the stock analysis
Jump to another research area for this company.